STAT

House progressives challenge drug makers to come back to Capitol Hill

The Congressional Progressive Caucus has invited executives from these six pharmaceutical companies to Capitol Hill to explain what they say are “out-of-control” price increases.
Congressional Progressive Caucus co-chairs Rep. Mark Pocan (D-Wis.) and Rep. Pramila Jayapal (D-Wash.)

WASHINGTON — House progressives on Wednesday called for executives from six drug companies to appear on Capitol Hill next week to justify what the lawmakers termed unjustifiable price increases — the latest public display of displeasure from the Democratic Party’s left flank regarding House Speaker Nancy Pelosi’s approach to lowering pharmaceutical costs.

The companies include four brand-name drug manufacturers: Merck, Eli Lilly, Gilead, and Pfizer, a spokeswoman said. The progressives also invited executives from two generic manufacturers: Mylan, the manufacturer of EpiPen, and Mallinckrodt, a company accused of paying

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy Insurance Coverage, Zepbound Shortages, And More
The first major U.S. health insurers have agreed to start paying for the Wegovy weight loss drug for certain people on Medicare with heart conditions.
STAT1 min read
Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
STAT1 min read
STAT+: Pharmalittle: We’re Watching A Ban Of Compounded Versions Of GLP-1s, A Biogen Acquisition, And More
Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalittle campus. I’m not a coffee drinker, but who needs caffeine when you’ve got the raw adr

Related Books & Audiobooks